If you have treatment-resistant depression, finding an effective therapy can feel like a never-ending battle. Traditional treatments such as psychiatric medications and even standard forms of ketamine infusion therapy can help some individuals, but not all achieve the long-lasting relief they hope for. Recognizing this need, Dr. Raul J. Rodriguez, MD, at Delray Brain Science, has pioneered a solution known as RMOKI therapy, a type of ketamine iv infusion therapy, which offers extended relief for those battling depression.
So, what makes RMOKI therapy stand out, how it differs from traditional ketamine iv infusion therapy treatments, and the incredible benefits it offers for those with depression and chronic pain disorders?
RMOKI therapy builds on the success of ketamine infusion therapy, which has shown a remarkable 90% success rate for treating treatment-resistant depression over the past decade. Traditional ketamine treatment typically involves either intravenous (IV) infusions or nasal inhalers to deliver the medication into the bloodstream, resulting in rapid symptom relief. However, some patients find that the relief they experience from these treatments doesn’t last as long as they would like. This is where RMOKI therapy comes in.
RMOKI (Rapid Multiple-Mode of Ketamine Infusion) therapy is a more comprehensive approach to ketamine treatment. It combines two methods of administration: a traditional IV infusion and a subcutaneous infusion. Both are administered simultaneously, creating a collaborative effect that allows patients to experience instant relief from depression symptoms while benefiting from the extended-release properties of the subcutaneous infusion. This means that the positive effects of ketamine last much longer than traditional infusions, giving patients the chance to enjoy relief for several weeks after treatment.
The combination of IV infusion and subcutaneous infusion is what sets RMOKI therapy apart. Traditional ketamine treatments deliver the medication directly into the bloodstream, providing rapid relief. While this is effective, the effects often wear off quickly, requiring frequent infusions to maintain symptom control.
With RMOKI therapy, the IV infusion still delivers an immediate antidepressant effect, but the subcutaneous infusion allows for a slow and steady release of the medication over time. This ensures that patients experience the initial benefits immediately, and continue to feel relief from their depression symptoms for weeks after the treatment. This longer-lasting effect reduces the need for frequent treatments, making the therapy more efficient and cost-effective for patients.
Extended Symptom Relief: One of the most notable advantages of RMOKI therapy is its long-lasting effects. Patients who may not have experienced extended relief from traditional ketamine infusions often find that RMOKI therapy provides them with weeks of symptom relief after just one session. This is particularly beneficial for individuals with treatment-resistant depression, allowing them to go longer between treatments while maintaining mental well-being.
Cost Efficiency: Due to the longer-lasting effects of RMOKI therapy, patients typically require fewer treatments than with traditional ketamine infusions. This not only saves time but can also result in cost savings for individuals managing chronic mental health conditions.
Immediate Antidepressant Effect: Patients receiving RMOKI therapy still benefit from the instantaneous relief that ketamine offers. This means that within the first treatment session, many individuals experience a dramatic reduction in their depressive symptoms, making it a fast-acting solution for those in acute distress.
Relief for Chronic Pain Conditions: In addition to helping with depression, RMOKI therapy can be highly effective in managing chronic pain disorders such as fibromyalgia. Ketamine has been shown to help reduce chronic pain by targeting certain pathways in the brain and nervous system. This dual benefit makes RMOKI therapy a game-changer for individuals dealing with both depression and chronic pain.
RMOKI therapy is ideal for individuals who:
At Delray Brain Science, we are committed to providing cutting-edge, holistic treatment options for individuals living with depression and chronic pain. With RMOKI therapy, we offer a unique approach that enhances the benefits of ketamine therapy and ensures that patients experience longer-lasting relief. Our team, led by Dr. Raul J. Rodriguez, has successfully treated hundreds of patients with ketamine therapy, and we are excited to bring the innovative RMOKI therapy to our patients for even better outcomes.
If you or a loved one is battling treatment-resistant depression or a chronic pain condition, RMOKI therapy at Delray Brain Science may help you find lasting relief. By combining IV and subcutaneous infusions, this treatment offers extended symptom relief, cost efficiency, and immediate antidepressant effects, providing a new hope for those who have struggled with traditional treatment methods.
To learn more about RMOKI therapy and how it can help you, contact Delray Brain Science today.
